0

March 10, 2016 AT 12:30 am

Dr. Gilda A. Barabino #WHM16 #WomensHistoryMonth #WomenInSTEM

Adafruit womens history blog

NewImage

Dr. Gilda A. Barabino is the Dean of The Grove School of Engineering at The City College of New York and is known for her research of sickle cell disease, biomedical engineering as well as her inquiry into race, ethnicity and gender within science and engineering.

From The City College of New York:

Dr. Barabino received her B.S. degree in Chemistry from Xavier University of Louisiana and her Ph.D. in Chemical Engineering from Rice University. She is a Fellow of the American Association for the Advancement of Science, the American Institute for Medical and Biological Engineering (AIMBE) and the Biomedical Engineering Society (BMES). She was the Sigma Xi Distinguished Lecturer for 2012-2014. She has an extensive record of leadership and service in the chemical and biomedical engineering communities. She is the Immediate Past-President of BMES and is the President-Elect of AIMBE. Dr. Barabino has over a decade of experience in leading NSF initiatives for women and minority faculty and is the founder and Executive Director of the National Institute for Faculty Equity.

Read more about Dr. Gilda A. Barabino here and learn more about the Barabino Laboratory here


Check out all the Circuit Playground Episodes! Our new kid’s show and subscribe!

Have an amazing project to share? Join the SHOW-AND-TELL every Wednesday night at 7:30pm ET on Google+ Hangouts.

Join us every Wednesday night at 8pm ET for Ask an Engineer!

Learn resistor values with Mho’s Resistance or get the best electronics calculator for engineers “Circuit Playground”Adafruit’s Apps!


Maker Business — Undercover in an iPhone Factory (video)

Wearables — Go with silicone

Electronics — Shift away from basic arithmetic

Biohacking — Recording and Biohacking a 100 Mile Run

Get the only spam-free daily newsletter about wearables, running a "maker business", electronic tips and more! Subscribe at AdafruitDaily.com !



No Comments

No comments yet.

Sorry, the comment form is closed at this time.